Eucrates Biomedical Acquisition Corp.
Status: Liquidated
U=S+W/3
W=S@11.5
| IPO Proceeds, $M | $104.80M |
|---|---|
| IPO Date | Oct 23, 2020 |
| CEO | Parag Saxena |
| Left Lead | Stifel Nicolaus |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 + 6 |
| IPO Sector | Healthcare ▶ |
| IPO Geography | US/Canada |
| Target Company | N/A |
| Deal Announced | N/A |
| Deal Size, $M | TBD |
| Deal Sector | TBD |
| Deal Geography | TBD |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | TBD |
| Amendment Vote | Oct 24, 2022 |
| Closing Date | Apr 26, 2023 |
EUCR
EUCRU
EUCRW
| Price | |
|---|---|
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.